---
title: DMCM2020
layout: default
permalink: /DMCM2020
---



<img src="../images/places/covid-19-banner.jpg"/>

The key theme of the 2020 Disease Maps Community Meeting is <a href="https://covid.pages.uni.lu/map_curation">COVID-19</a>. The event is organised as a virtual conference by the <a target="_blank" href="https://wwwen.uni.lu/lcsb">Luxembourg Centre for Systems Biomedicine</a>.

## Key dates

Abstract submission deadline: **EXTENDED until 31 October 2020**  
Acceptance notification: **30 October 2020**  
Final programme: **2 November 2020**  
Registration deadline: **5 November 2020**  
DMCM2020: **12-14 November 2020**  

Abstract submission deadline: <strong><font color="red">EXTENDED until 31 October 2020</font></strong><br />  
Acceptance notification: <strong>30 October 2020</strong>  <br />
Final programme: <strong>2 November 2020</strong>  <br />
Registration deadline: <strong>5 November 2020</strong>  <br />
DMCM2020: <strong>12-14 November 2020</strong> 

## Abstract submission

Please submit your abstract up to 400 words via this <a href="https://easychair.org/conferences/?conf=dmcm2020"><strong><font color="Navy">submission link</font></strong></a> by <font color="red">25 October 2020</font>.   

<!--<p style="color:red;">Abstract submission deadline: <strong><font color="red">31 October 2020 (extended)</font></strong>.</p>-->


## Registration

The registration is free but mandatory. Please fill in the <a href="https://forms.gle/6wjFaQ68fCptdvQW6"><strong><font color="Navy">registration form here</font></strong></a> by <font color="red">5 November 2020</font>.  

<!--Registration deadline: **5 November 2020**.
<p style="color:red;">Registration deadline: <strong><font color="red">5 November 2020</font></strong>.</p>-->

## Virtual environment

This webpage is the main entry point for accessing all events of the programme.  We run this meeting using a combination of the virtual platform ZENODO and Webex Meetings. The live talks and the discussion panels will take place in Webex rooms, whereas the personal profiles of the participants and virtual posters (PDFs plus 7 minutes pre-recorded videos) will be displayed on the ZENODO platform.  Upon agreement with the speakers, the live talks will be recorded and also displayed on the ZENODO platform right after the session.  

## How to?

The detailed instructions about profile generation, poster standards, video recordings, materials unloading to the ZENODO platform, etc. will be provided right after the abstract notification announcement.  
 
## If I am just an attendee?

We encourage everyone to submit the abstract and present the work. However, attendance without project presentation is also welcome. The attendees need to register to the meeting by 5 November 2020. The explanations on the virtual modalities of the presentations, discussion and posters will be available on the meeting website.  
 
## Topics

The key theme of the 2020 Disease Maps Community Meeting is COVID-19. The first day of the meeting will be dedicated to COVID-19, the second and the third days will be dedicated to ongoing community projects.  
 
We also welcome talks, posters and discussions on other topics relevant to disease maps: ongoing disease map projects, related technologies and disease map applications.  
 
The programme will contain keynotes, invited talks and talks selected from abstracts. We’ll hold several parallel discussion panels on the major burning topics in the field. All virtual posters will be exposed on the ZENODO platform. 

## Invited speakers

<!--<table>
<tr>
<td style="width: 130px;"><img src="../images/teamhq/VassiliSoumelis.jpg" alt="Vassili Soumelis" width="130"/></td>
<td><strong>Vassili Soumelis, MD, PhD, Hôpital St Louis, Paris, France</strong><p style="line-height:150%; font-size:13px; padding-top:6px; text-align:justify">Text</p></td>
</tr>
<tr>
<td style="width: 130px;"><img src="../images/teamhq/OlivierLantz.jpg" alt="Olivier Lantz" width="130"/></td>
<td><strong>Olivier Lantz, MD, PhD, Institut Curie, Paris, France</strong><p style="line-height:150%; font-size:13px; padding-top:6px; text-align:justify">Text</p></td>
</tr>
</table>-->

<table>
<tr>
<td style="width: 220px;"><p style="margin:4px;"><img src="/images/teamhq/VassiliSoumelis.jpg" width="150"/></p></td>
<td style="width: 220px;"><p style="margin:4px;"><img src="/images/teamhq/OlivierLantz.jpg" width="150"/></p></td>
<td style="width: 220px;"><p style="margin:4px;"><img src="/images/teamhq/ChrisSander.jpg" width="150"/></p></td>
</tr>
<tr>
<td style="width: 220px;"><p style="margin:4px;"><strong>Vassili Soumelis, MD, PhD</strong></p><p style="margin:4px; line-height:100%;"><font size="2">Hôpital St Louis, Paris, France</font></p></td>
<td style="width: 220px;"><p style="margin:4px;"><strong>Olivier Lantz, MD, PhD</strong></p><p style="margin:4px; line-height:100%;"><font size="2">Institut Curie, Paris, France</font></p><br /></td>
<td style="width: 220px;"><p style="margin:4px;"><strong>Chris Sander, PhD</strong></p><p style="margin:4px; line-height:100%;"><font size="2">Dana–Farber Cancer Institute, Harvard Medical School, Boston, US</font></p><br /></td>
</tr>
<tr>
<td style="width: 220px;"><p style="margin:4px;"><img src="/images/teamhq/MariaMartin.jpg" width="150"/></p></td>
<td style="width: 220px;"><p style="margin:4px;"><img src="/images/teamhq/DagmarWaltemath.jpg" width="150"/></p></td>
<td style="width: 220px;"> </td>
</tr>
<tr>
<td style="width: 220px;"><p style="margin:4px;"><strong>Maria-Jesus Martin, PhD</strong></p><p style="margin:4px; line-height:100%;"><font size="2"><!--European Molecular Biology Laboratory, European Bioinformatics Institute-->EMBL-EBI, Cambridge, UK</font></p></td>
<td style="width: 220px;"><p style="margin:4px;"><strong>Dagmar Waltemath, PhD</strong></p><p style="margin:4px; line-height:100%;"><font size="2">Greifswald University Hospital, Greifswald, Germany</font></p></td>
<td style="width: 220px;"> </td>
</tr>
</table>

## Confirmed talks

| **The Curiosa study: high seroprevalence but short-lived immune response to SARS-CoV-2 infection in Paris**<br />_[Olivier Lantz](https://institut-curie.org/personne/olivier-lantz), Institut Curie, Paris, France_ |
| **Informatics resources for COVID-19 proteomics, viral evolution and drug effects** <br />_[Chris Sander](https://www.dfhcc.harvard.edu/insider/member-detail/member/chris-sander-phd/), Dana–Farber Cancer Institute, Harvard Medical School, Boston, US_ | 
| **Deciphering molecular mechanisms of disease: a view on protein knowledge and disease maps**<br />_[Maria-Jesus Martin](https://www.ebi.ac.uk/about/people/maria-jesus-martin), European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Cambridge, UK_ |
| **Adding value to scientific results using COMBINE standards and guidelines for modelling and simulation in systems medicine**<br />_[Dagmar Waltemath](https://www.fis.med.uni-greifswald.de/FIS/init_person_browser.action?pers_id=ngpocpv7uc2ss), Greifswald University Hospital, Greifswald, Germany_ |
  

## Programme

The programme will be available soon.

<!--The time is shown for Paris: Central European Time (CET) &ndash; **UTC/GMT +1 hour**
### Thursday 12 November
#### 9:00 - 12:00 Session 1
#### 13:00 - 16:00 Session 2
#### 16:00 - 18:00 Poster session
### Friday 13 November
#### 9:00 - 12:00 Session 3
#### 13:00 - 16:00 Session 4
### Saturday 14 November
#### 10:00 - 12:00 Breakout discussions
#### 14:00 - 15:00 Summary
#### 15:00 - 15:30 Conclusions-->

## Contact

For any questions please contact organisers at [dmcm-organisers@googlegroups.com](mailto:dmcm-organisers@googlegroups.com).

## Acknowledgements

We would like to thank Marion Ferraez for her help with the design of the event page.

## Organisers

### Event organisers

<p><a href="mailto:marek.ostaszewski@uni.lu">Marek Ostaszewski</a>  
<br /><a href="mailto:inna.kuperstein@curie.fr">Inna Kuperstein</a>  
<br /><a href="mailto:anna.niaraki@univ-evry.fr">Anna Niarakis</a>  
<br /><a href="mailto:a.mazein@gmail.com">Alexander Mazein</a>  
<br /><a href="mailto:reinhard.schneider@uni.lu">Reinhard Schneider</a>  
</p>

### Disease Maps Project Coordinators

<p><a href="mailto:a.mazein@gmail.com">Alexander Mazein</a>
<br /><a href="mailto:marek.ostaszewski@uni.lu">Marek Ostaszewski</a>
<br /><a href="mailto:inna.kuperstein@curie.fr">Inna Kuperstein</a>
<br /><a href="mailto:anna.niaraki@univ-evry.fr">Anna Niarakis</a>
<br /><a href="mailto:andrei.zinovyev@curie.fr">Andrei Zinovyev</a>
<br /><a href="mailto:reinhard.schneider@uni.lu">Reinhard Schneider</a>
<br /><a href="mailto:emmanuel.barillot@curie.fr ">Emmanuel Barillot</a>
<br /><a href="mailto:rudi.balling@uni.lu">Rudi Balling</a>
<br /><a href="mailto:cauffray@eisbm.org">Charles Auffray</a>
</p>

<!--## Contact-->

<!--## Co-organizers-->
